Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2026
Prognostic Value of Late Gadolinium Enhancement Findings in Isolated Left Ventricular Dilatation and Dilated Cardiomyopathy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gonçalves Trecy, Duhamel Suzanne, Toupin Solenn, Sanguineti Francesca, Garot Philippe, Unterseeh Thierry, Hovasse Thomas, Akodad Mariama, Champagne Stéphane, Chevalier Bernard, Neylon Antoinette, Gall Emmanuel, Martial Paul-Jun, Ballout Edouard, Mirailles Raphael, Sibilia Benjamin, Unger Alexandre, Bondue Antoine, Florence Jeremy, Dillinger Jean Guillaume, Henry Patrick, Bousson Valérie, Garot Jérôme, Pezel Théo
Аннотация
BACKGROUND: Non-ischemic dilated cardiomyopathy (DCM) and isolated left ventricular dilatation (ILVD) are defined as left ventricular (LV) dilatation, with reduced or preserved left ventricular ejection fraction (LVEF), respectively. We aimed to assess the prognostic value of late gadolinium enhancement (LGE) findings, including LGE extent, location, and number of areas to predict all-cause death in ILVD and DCM, separately.
METHODS: Between 2008 and 2021, we conducted a bicentric retrospective study including all consecutive ILVD and DCM patients referred for cardiovascular magnetic resonance (CMR). The primary outcome was all-cause death. A propensity-score matching was performed to balance characteristics between ILVD and DCM populations. Cox regressions were performed to determine the prognostic value of each LGE feature.
RESULTS: Of 2,752 patients (age 52±8 years, 56% males), 408 (15%) patients died after a median (interquartile range) follow-up of 9 (7-12) years, including 268 (16%) of 1,668 DCM patients and 140 (13%) of 1,084 ILVD patients. Overall, 737 (27%) patients had LGE, including 472 (28%) of 1,668 DCM patients and 265 (24%) of 1,084 ILVD patients. After propensity-score matching, in ILVD patients with LGE (N=265), the LGE extent (hazard ratio [HR] 1.38, 95% confidence interval [CI]: 1.06-1.78, p=0.015), multiple LGE areas (HR=3.39, 95% CI: 1.66-6.92, p<0.001), and its septal location (HR=2.68, 95% CI: 1.59-4.52, p<0.001) were strong prognosticators of death after adjustment. Similarly, after propensity-score matching, in DCM patients with LGE (N=277), the LGE extent (HR=1.39, 95% CI: 1.06-1.83, p=0.018), multiple LGE areas (HR=2.70, 95% CI: 1.20-6.08, p=0.017), and its septal location (HR=2.82, 95% CI: 1.47-5.41, p=0.002) were strongly associated with death. The CMR LGE score performed well in participants with LGE (area under the curve [AUC] at 10 years, 0.79 [95% CI: 0.69-0.89]).
CONCLUSIONS: LGE findings were strongly and independently associated with death in both ILVD and DCM patients, with each successive LGE characteristic providing significant incremental prognostic value beyond traditional prognosticators, including LVEF.
METHODS: Between 2008 and 2021, we conducted a bicentric retrospective study including all consecutive ILVD and DCM patients referred for cardiovascular magnetic resonance (CMR). The primary outcome was all-cause death. A propensity-score matching was performed to balance characteristics between ILVD and DCM populations. Cox regressions were performed to determine the prognostic value of each LGE feature.
RESULTS: Of 2,752 patients (age 52±8 years, 56% males), 408 (15%) patients died after a median (interquartile range) follow-up of 9 (7-12) years, including 268 (16%) of 1,668 DCM patients and 140 (13%) of 1,084 ILVD patients. Overall, 737 (27%) patients had LGE, including 472 (28%) of 1,668 DCM patients and 265 (24%) of 1,084 ILVD patients. After propensity-score matching, in ILVD patients with LGE (N=265), the LGE extent (hazard ratio [HR] 1.38, 95% confidence interval [CI]: 1.06-1.78, p=0.015), multiple LGE areas (HR=3.39, 95% CI: 1.66-6.92, p<0.001), and its septal location (HR=2.68, 95% CI: 1.59-4.52, p<0.001) were strong prognosticators of death after adjustment. Similarly, after propensity-score matching, in DCM patients with LGE (N=277), the LGE extent (HR=1.39, 95% CI: 1.06-1.83, p=0.018), multiple LGE areas (HR=2.70, 95% CI: 1.20-6.08, p=0.017), and its septal location (HR=2.82, 95% CI: 1.47-5.41, p=0.002) were strongly associated with death. The CMR LGE score performed well in participants with LGE (area under the curve [AUC] at 10 years, 0.79 [95% CI: 0.69-0.89]).
CONCLUSIONS: LGE findings were strongly and independently associated with death in both ILVD and DCM patients, with each successive LGE characteristic providing significant incremental prognostic value beyond traditional prognosticators, including LVEF.